Archive - 2014

19 December 2014 - Press Releases

Karus Therapeutics presenting at Biotech Showcase 2015

Dr Simon Kerry, CEO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting at Biotech Showcase 2015, 12-14 January 2015 in San Francisco.

Read more

Abstracts

Design and Development of Novel, Highly-Selective HDAC6 Inhibitors for the Treatment of Cancer.
Cecil A., Rogers H., Bone E., Colman L., Finan P., Haque K., Lensun L., Roitt R., Silva F., Ward P., Whale A., Shuttleworth S.
NCRI Meeting, Liverpool, UK, November 3, 2014, A114.

Abstracts

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/d Inhibitors for the Treatment of Cancer.
Cecil A., Rogers H., Bone E., Colman L., Finan P., Haque K., Lensun L., Roitt S., Silva F., Ward P., Whale A. Shuttleworth S.
NCRI Meeting, Liverpool, UK, November 3, 2014, A143.

Events

2-5 Nov 2014
NCRI, Liverpool, UK

21 October 2014 - Press Releases

Karus Therapeutics Appoints New Head of Clinical Development and Head of Biology

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory diseases and cancer, today announced that it has further strengthened its R&D team with two new appointments; Dr Simon Roitt, who joins as Head of Clinical Development and Dr Peter Finan, who has been appointed as Karus’s Head of Biology.

Read more

Events

7 Oct 2014
UK Bioscience Forum, London, UK

Events

30 Sep-01 Oct 2014
SACHS Biotech in Europe Forum, Basel, Switzerland

29 September 2014 - Press Releases

Karus Therapeutics presenting at NCRI Cancer Conference

Stephen Shuttleworth, CSO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting two posters at the 10th NCRI Cancer Conference, 2-5 November 2014 in Liverpool.

Read more

08 September 2014 - Press Releases

Karus Therapeutics presenting at SACHS Biotech in Europe Forum

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that Simon Kerry, CEO, will be presenting at the SACHS Biotech in Europe Forum, 30 September – 01 October, 2014 in Basel, Switzerland.

Read more

Events

19 June 2014
European MediScience Awards Dinner, London, UK

15 May 2014 - In the News

Karus Therapeutics features in SciBX

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured in the cover story of SciBX, ‘Chromatin’s rising tide’.

Read more

Events

12-14 May 2014
BioTrinity 2014, London, UK

Events

5-9 April 2014
AACR, San Diego, USA

Abstracts

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/δ Inhibitors for the Treatment of Cancer.
Shuttleworth S.J., Bone E.A., Cecil A.R.L., Colman L., Fulton R., Haque K., Hill T.J., McGovern Y., Nodes W.J., Rogers H., Silva F.A., Whale A.D.
Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr LB-7.

Abstracts

Design and Development of a Novel Series of HDAC6-Selective Inhibitors for the Treatment of Cancer.
Shuttleworth S.J., Bone E.A; Cecil A.R.L., Colman L., Fulton R., Hill T.J., McCormick S., Nodes W.J., Rogers H., Silva F.A., Tomassi C.D., Whale A.D.
Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr LB-8.

03 April 2014 - Press Releases

Karus Therapeutics presenting at AACR Annual Meeting 2014

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that it will be giving two poster presentations at the AACR Annual Meeting in San Diego, 5-9th April 2014.

Read more

25 February 2014 - In the News

Karus Therapeutics showcased in BVCA’s Britain’s Hot Talents 2014/15

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has been featured in the British Private Equity and Venture Capital Association (BVCA)’s handbook of venture capital innovation, Britain’s Hot Talent.

Read more

Events

13-16 Jan 2014
Biotech Showcase and J.P. Morgan 32nd Annual Healthcare Conference, San Francisco, USA